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ABSTRACT 
  L-Asparaginase is an amidohydrolase that catalyzes the hydrolysis of amino acid L-
asparagine into aspartic acid and ammonia. It is used in the treatment of Acute 
Lymphoblastic Leukemia (ALL) and some other malignant lymphoid abnormalities. It is 
also used in food industry to prevent the formation of acrylamide, a carcinogenic substance 
in carbohydrate rich fried and baked foods. Naturally L-Asparaginase is present in plants, 
animals and microbes but microorganisms such as bacteria, yeast and fungi are generally 
used for the production of L-Asparaginase as it is difficult to obtain the same from plants 
and animals. It is found that the L-Asparaginase from bacteria causes side effects in humans 
including anaphylaxis and serious allergic reactions which can be fatal in some cases. To 
overcome this, eukaryotic organisms such as fungi can be used for the production of L-
Asparaginase. But sometimes the fungi produces L-glutaminase and urease enzymes along 
with L-Asparaginase which is difficult to remove in the purification stage. In order to 
prevent this fungal strains which can produce L-Asparaginase free of L-glutaminase and 
urease are isolated from different sources using standard protocols.  
In the current study four novel fungal strains (C3-Aspergillus sps, C7-Aspergillus sps, W3-
Rhizopus sps, W5-Rhizopus sps) producing L-Asparaginase free of L-glutaminase and 
urease are screened from a total of 40 fungal sps isolated from various soil samples and 
agricultural substrates collected from different locations. Activity studies are conducted for 
all these species according to standard protocols. Fungus with high enzyme index (C7)  
1.57 was then subjected to Solid State Fermentation (SSF) studies in flasks and the results 
were compared with that of flask level Submerged Fermentation (SmF). The strain C7 is 
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found to have the highest activity of 44.09 U/ml in SmF and 22.41 U/ml in SSF at 72 hour 
of incubation at 35 ° C and 180 rpm.  
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Chapter 1 
INTRODUCTION 
1.1 Generalities 
L-Asparaginase (E.C. 3.5.1.1) is an enzyme which is found in a wide range of organisms 
including plants, microbes, animals and in the serum of certain rodents but not in human 
beings. It is an amidohydrolase, which catalyzes the hydrolysis of the amide group on the 
side chain of asparagine, an amino acid into aspartic acid and ammonia. It was first found 
to be present in the serum of guinea pigs by J G Kidd in 1953. He observed that the enzyme 
has tumor inhibitory properties and showed that transplanted lymphomas of mice and rat 
are repressed in vivo by repeated injections of guinea pig serum [1]. Because of its anti-
tumor activities L-Asparaginase is used mainly in the treatment of Acute Lymphoblastic 
Leukemia (ALL). It is also used in the food industry to prevent the formation of acrylamide 
in fried food items [2]. L-Asparaginase is present in plants and mammals, since the 
extraction is difficult microbial sources especially bacteria and fungi are evaluated as 
potential source of enzyme production [3]. 
Figure 1. Hydrolysis reaction of L-Asparaginase on asparagine 
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1.2 L-Asparaginase in tumor treatment and its mechanism 
Acute lymphoblastic leukemia (ALL) which mostly affects children is a form of cancer in 
which the bone marrow produces too many immature lymphocytes leading to reduced 
immunity. L-Asparaginase enzyme is used as a chemotherapy drug for the treatment of 
ALL. It is also used in the treatment of a number of lymphocytic cancers including 
Hodgkin’s disease, non-Hodgkin’s lymphoma, melanosarcoma etc. Normal cells can 
synthesize L-asparagine by itself because of the presence of the enzyme asparagine 
synthetase, whereas certain sensitive malignant cells cannot synthesize it by itself and 
require an external source of L-asparagine for optimal growth. During the treatment of  
ALL with L-Asparaginase, all the circulating asparagine in the body of the patient get 
hydrolyzed to aspartic acid and ammonia preventing the absorption of asparagine by 
tumor cells and hence depriving the dependent tumor cells of their extracellular source of 
L-asparagine. The asparagine deficiency rapidly impairs the protein synthesis and leads 
to delay in DNA and RNA synthesis and hence impairs the cell functioning finally 
resulting in cell death [4, 5]. L-Asparaginase is commonly used as a combination 
chemotherapy drug for the treatment of acute lymphoblastic leukemia (ALL) in children.  
 Unfortunately, despite the wide use of L-Asparaginase, most of the treatments have been 
interrupted due to severe side effects and immunological reactions in the patients. The side 
effects include anaphylaxis, coagulation abnormality, thrombosis, liver dysfunction, 
pancreatitis, hyperglycemia, cerebral dysfunction etc. These side effects are developed 
either due to the production of anti-asparaginase antibody in the body or due to multiple 
enzymatic activity of the produced enzyme [6]. Toxicity of L-Asparaginase is mainly due 
to the fact that the enzyme preparations are amidohydrolase, not L-Asparaginase.  L- 
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Glutaminase and urease are usually associated with the L-Asparaginase isolated from most 
of the bacteria and fungi and it is very difficult to separate them in the purification stage 
[7]. These enzymes hydrolyze L-glutamine and urea in the body, thereby preventing 
kidney, central nervous system and other vital organs from normal functioning thus leading 
to serious side effects [8, 9]. 
1.3 Applications in food industry 
This Enzyme is also used in the food industry to prevent the formation of acrylamide, a 
carcinogenic substance during frying or baking of food items containing starch at high 
temperatures [10]. The reaction is a result of heat induced Maillard reaction (or non-
enzymatic browning reaction) between amino acid group of asparagine and carbonyl 
group of reducing sugar which provides desirable flavor to the food. On addition of the 
enzyme the asparagine in the food gets converted to aspartic acid and ammonia hence 
preventing the formation of acrylamide. 
Figure 2. Maillard reaction of asparagine and glucose leading to the formation of 
acrylamide
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L-Asparaginase production throughout the world is carried out either by submerged 
fermentation (SmF) or solid state fermentation (SSF).  SSF is defined as the growth of 
microorganism on solid substrate which acts as an energy source in the absence of free 
flowing water. SSF is a substitute to submerged fermentation for the large scale production 
of industrial enzymes. The solid substrates used in SSF are mainly agricultural or 
industrial wastes which are cheap and has resistance to contamination especially for the 
large scale production of fungal enzymes. Therefore SSF can be used as a better method 
for the large scale production of L-Asparaginase. 
1.4 Methods of production: Comparison of SSF and SmF 
L-Asparaginase production throughout the world is carried out either by submerged 
fermentation (SmF) or solid state fermentation (SSF). Submerged fermentation is a process 
in which the growth of microorganisms takes place in liquid broth medium which is 
optimized with required nutrients to have a better cultivation of micro-organisms. This 
involves growing carefully the selected microorganisms in closed reactor containing the 
fermentation medium and a high concentration of oxygen. Submerged fermentation has 
well established equipment that make use of the existing micro-organisms. Bacteria is 
commonly used as source in this process as it requires high moisture content.   
SSF is defined as the growth of microorganism on solid substrate which acts as an energy 
source in the absence of free flowing water [11]. SSF is a substitute to submerged 
fermentation for the large scale production of industrial enzymes. The solid substrates used 
in SSF are mainly agricultural or industrial wastes which are cheap and has resistance to 
contamination especially for the large scale production of fungal enzymes. 
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Compared to submerged fermentation SSF has many advantages, among those the most 
important thing is that it provides high yield and activity of the enzyme and the process is 
eco-friendly because it makes use of agricultural waste as the substrate and since the 
moisture content is low it avoids the need to treat a huge amount of effluent water. These 
factors avoid environmental pollution to a considerable extent. 
SSF has disadvantages as well. The heat produced in SSF reactor is difficult to dissipate 
effectively hence it often leads to heat buildup which affects the growth of the fungi. The 
solid mass prevents effective diffusion of oxygen and the controlling of process parameters 
are really difficult. 
 
Table 1. Comparison of SSF and SmF for enzyme production 
Advantages Limitations 
Submerged 
Fermentation 
Solid state fermentation Submerged 
Fermentation 
Solid state 
fermentation 
Better heat and 
mass transfer 
can be achieved  
 
Low water requirement, 
resistance to 
contamination 
 
 
Complex in 
operation, Low 
yield. 
 
Heat build up 
Difficulties to ensure 
proper oxygen diffusion 
Better diffusion  
of 
microorganism 
 
Better diffusion 
of oxygen  
 
No effluent water 
 
Substrate are agricultural 
wastes 
High energy 
consumption and 
cost intensive 
 
Large scale inoculums 
and difficult to control 
process parameters 
 
Commercially 
available in 
large scale 
 
High yield and product 
activity 
 
High release of 
effluents 
 
Difficulties in scale-up 
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1. 5 Objectives and scopes 
Based on an extensive literature survey on the production of L-Asparaginase and 
characterization, the present study focused on isolation of a novel fungal strain for the 
production of glutaminase and urease free L-Asparaginase.  The following objectives have 
been envisaged in the present investigation: 
 
 Isolation and screening of potential glutaminase and urease free L-Asparaginase 
producing fungal strains from soil and agricultural samples. 
 Identification of the strain with the maximum enzyme index. 
 Comparison of activity studies in SmF and SSF. 
 
These four strains C3, C7, W3 and W5 are free of glutaminase and urease and are found to 
have good L-Asparaginase activity and hence have high potential in the treatment of ALL. 
This is the first report on L-Asparaginase producing strain free of glutaminase and urease 
elsewhere reported in the literature. 
1.6 Organization of thesis 
 
The presentation of the work has been divided into five chapters. The current Chapter 1 
presents a general introduction, objective and scope of the present work. While the 
literature that supports the work is presented in Chapter 2. Chapter 3 includes the details 
of the materials and methods adopted in the present study. It explains the procedures and 
protocols used in the study. Chapter 4 contains the results and discussions. This chapter 
discusses in detail about the four isolates which are free of glutaminase and urease activity 
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and its SmF and SSF activity studies. Chapter 5 draws summary and appropriate 
conclusions based on the previous results and discussions. It also provides some useful 
recommendations to carry out further work in this field. 
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Chapter 2 
LITERATURE REVIEW 
 
2.1 L-Asparaginase 
L-Asparaginase (L-Asparaginase amidohydrolase EC 3.5.1.1) is the enzyme having 
antitumor activity and obtained from various biological sources viz., plants, animals and 
many other microorganisms (fungus, yeast, bacteria etc.). The enzyme acquired clinical 
importance in 1961 when the antitumor effect of Guinea pig serum originally discovered 
by Kidd. It has been used in leukemia treatment last four decades. The most common 
therapeutic indications are treatment of Hodgkin disease, acute lymphocytic leukemia 
(mainly in children), acute myelocytic leukemia, acute myelomonocytic leukemia, and 
chronic lymphocytic leukemia, lymphosarcoma treatment, reticle sarcoma and 
melanosarcoma. Recently, some more applications of L-Asparaginase have been reported 
in acrylamide free food production. 
2.2 Historical development 
The pioneer observation that turned out to be important for the development of L-
Asparaginase as a potential antineoplastic agent was made by Clementi in 1922 revealing 
the presence of high activity of L-Asparaginase in the serum of guinea pig. High L-
Asparaginase activity was observed only in guinea pig serum, whereas other mammals 
were found devoid of this enzyme [12]. Later in 1953 J G Kidd showed that transplanted 
lymphomas of mice and rat are repressed in vivo by repeated injections of guinea pig serum 
and found that some active constituent in serum is responsible for the selective necrosis of 
lymphoma cells [13]. The studies took another turn when Neumann and McCoy has 
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observed in 1956 that the basically non-essential amino acid asparagine is needed to grow 
the Walker carcinosarcoma 256 in vitro [14]. Haley and co-workers have found that murine 
L5178Y leukemia cells also require asparagine for in vitro growth in 1961 [15]. Broome 
also observed the same results in 1961 with his experiments with 6C3HED cell lines [16]. 
It was Broome who later in 1963 came up with the theory that the antitumor activities of 
guinea pig serum is due to the presence of the enzyme L-Asparaginase in it [17]. Looking 
at the biochemical reactions involved in these experiments it became evident that certain 
leukemic blast cells are sometimes unable to synthesize enough asparagine for their own 
metabolism, so that the asparaginase-induced deficiency in asparagine will impair cellular 
function and eventually cause cellular death. So the specificity of L-Asparaginase towards 
L-asparagine is the reason behind this therapeutic effect. 
Furthermore, a major advancement resulted when Mashburn and Wriston in 1963 reported 
that asparaginase can be extracted from E.coli bacteria and it can inhibit the growth of 
tumor cell just like guinea pig serum [18].This opened the possibilities to produce and 
utilize the enzyme in larger quantities. It also leads to number of clinical studies [19]. The 
first clinical trials in patients with acute lymphoblastic leukemia were carried out with 
asparaginase preparations both from guinea pig serum and E. coli. Both enzymes showed 
clinical efficacy [20]. 
In the later years further studies identified more bacterial species with L-Asparaginase 
producing capability. Among those isolates Erwinia Chrisanthemi showed maximum 
activity and it was used for large scale production of the enzyme [21]. Even though a large 
number of strains were reported to have L-Asparaginase activity in the following years 
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including only E Coli and Erwinia Chrisanthemi species were widely used for large scale 
production. 
Treatment with E Coli protein was always found to be associated with hypersensitivity 
reactions. Whereas the Erwinia Chrisanthemi protein was found to have negligible or lesser 
side effects in clinical trials [22].  But both the protein have certain level of 
immunogenicity. Later it was found that coupling the derived protein with Poly Ethylene 
Glycol (PEG) group could preserve the activity of the enzyme for a longer time and could 
reduce the immunogenicity to certain extend [23]. It helped to reduce the hypersensitivity 
of the enzyme and allowed much less frequent administration of PEG-asparaginase 
compared to normal asparaginase. 
2.3 Chemistry and structural aspects of L-Asparaginase 
Enzymes with L-Asparaginase activity can be generally classified into two groups, the 
bacterial-type and the plant-type L-Asparaginases, characterized by different structural and 
biochemical features. The bacterial-type enzymes are further grouped into type I and type 
II depending on their cellular localization and substrate specificity. Type I includes 
cytosolic enzymes that exhibit low affinity for L-Asparaginase, whereas type II enzymes 
are localized in the periplasm and show considerably higher affinity for L-Asparaginase 
[24]. These enzymes from various sources have been purified and its biochemical 
properties are studied extensively over the last 4 decades. Type II asparaginase has a stable 
tetrameric structure composed of 4 identical sub units and each subunit contains 326 amino 
acid residues [25]. E.Coli asparaginase has molecular weight of approximately 130 kDa 
and the affinity constants for L-asparagine and L-glutamine are 1.15 x 10-5 and 6.25 X 10-
3 M, respectively.  The isoelectric point of crystalline type varies from 4.8 to 5.6 [26, 27]. 
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Whereas the molecular weight of Erwinia L-Asparaginase is between 135 - 138 kDa and 
specific activity of the purified enzyme lies between 300 and 400 mole of the substrate per 
minute per milligram of protein. The isoelectric point ranges between pH 4.6 and 5.5 for 
E. coli enzyme, and is around 8.7 for the Erwinia enzyme [28]. 
The amidohydrolase L-Asparaginase helps in the hydrolysis of non-essential amino acid 
asparagine into aspartic acid and ammonia. L-asparagine hydrolysis is known to proceed 
in two steps. In the first step a covalent intermediate, beta-acyl-enzyme intermediate is 
formed through nucleophilic attack by the threonine group on L-Asparaginase as shown in 
figure 3. In the second step, a water molecule attacks the acyl-enzyme intermediate to 
produce L-aspartate and ammonia [29]. The structure of E. coli L-Asparaginase was 
studied by Swain et al., (1993) and two domains were observed [25]. Location of the active 
site was found to be between the N and C terminals. Structure of the enzyme with bound 
L-aspartate indicated a threonine residue as a catalytic nucleophile by Miller et al. in 1993 
[30]. Hydrolysis reaction is assayed by measuring the release of ammonia using Nessler’s 
reagent or by measuring the release of L-aspartate. 
Figure 3. Schematic illustration of the reaction mechanism of L-Asparaginases. The 
proposed covalent intermediate is formed through nucleophilic attack by the enzyme. Bold 
arrows indicate nucleophilic attack                       
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2.4 Sources of L-Asparaginase 
Microorganisms are considered as effective sources for the production of therapeutic 
enzymes since microbes are easy to manipulate. Broad range of microorganisms such as 
filamentous fungi, yeast, actinomycetes and marine organisms are isolated from different 
sources. 
2.4.1 Bacterial L-Asparaginase 
L-Asparaginase production from various bacterial sources have been studied extensively 
over decades due to the flexibility with which bacteria’s can be manipulated. L-
Asparaginase from E.coli and Erwinia chrysanthemi are clinically used for the treatment 
of ALL. Bacterial asparaginase derived from various bacteria differ in pH, molecular 
weight, stability and affinity and they are serologically and biochemically different even 
though the toxicity, anti-neoplasticity and immunogenicity are similar. Bacterial 
formulations are found to have high immunogenicity in ALL treatment. Different bacterial 
isolates with L-Asparaginase activity reported in the literature are given in table 2. 
2.4.2 Fungal L-Asparaginase 
Bacterial L-Asparaginase is often associated with hypersensitive reactions in patients 
which can be fatal in some cases. This leads to the studies to identify fungal strains which 
are free of allergic and immunogenic reactions. Since the fungi are eukaryotic organisms 
and evolutionarily more close to human cell line the immunogenic side reactions are 
comparatively lesser for fungal asparaginase. The mitosporic fungi genera such as 
Aspergillus, Penicillium and Fusarium are commonly reported in the literature to produce 
asparaginase [31, 32, 33, 34].  Imada et al. observed that amidase activity is present in 
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fungal strains, Penicillium clavgorme and P. expansum. Sarquis et al., (2004) and Mishra, 
(2006) reported that the L-Asparaginase production by A. terreus and A. niger, respectively 
[8, 35]. Other isolates are given in the table. 
2.4.3   Actinomycetes L-Asparaginase 
Recently other than terrestrial based microorganisms focus has been shifted to marine 
microbes for the production of bioactive compounds.  Marine biosphere is a potential 
source of actinomycetes from which various antibiotics and bioactive compounds can be 
derived. L-Asparaginase from marine actinomycetes showed cytotoxic effects on acute T 
cell leukemia and mylegeneous leukemia [36].  Dharmraj (2011) reported production of L-
Asparaginase from marine actinomycetes, and purified enzyme showed a final specific 
activity of 78.88 IU/mg at pH 8 [37]. L-Asparaginase production from numerous 
actinomycetes such as Streptomyces ABR2, Streptomyces albidoﬂavus have been explored 
it is given in table 2.  
 
Table 2. Various microbial sources of L-Asparaginase 
Bacteria Reference Fungi Reference 
E. coli  [18] Aspergillus terreus [31] 
Erwinia aroideae  [38] Fusarium tricinctum [41] 
Serratia marcescens [39] Aspergillus niger [35] 
Erwinia carotovora [40] 
Aspergillus terreus 
MTCC 1782 
[42] 
Enterobacter 
aerogenes 
[43] Fusarium equiseti [54] 
Enterobacter 
aerogenes  
[44] Penicillium sp. [55] 
Thermus thermophilus  [45] Penicillium digitatum. [56] 
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Pseudomonas 
aeruginosa 50071 
[46] 
Cladosporium sp. 
Saccharomyces 
cerevisiae 
Rhodosporidium 
toruloides 
[57] 
[58] 
[59] 
Erwinia carotovora [47] Actinomycetes Reference 
Bacillus circulans 
MTCC 8574  
[48] 
Streptomyces 
albidoflavus. 
[60] 
Serratia marcescens 
SB08 
[49] Marine actinomycetes [61] 
Bacillus sp. [11] 
Streptomyces noursei 
MTCC 10469 
[37] 
Pectobacterium 
carotovorum MTCC 
1428 
[50] 
Streptomyces ABR2 
Nocardia sp. 
[62] 
[63] 
Serratia marcescence [51] 
Streptomyces 
longsporusflavus 
 
[64] 
Bacillus licheniformis 
Mycobacterium phlei 
Thermus aquaticus. 
[52] 
[53] 
[34] 
Streptomyces 
gulbargensis 
[65] 
 
2.5 Clinical availability of L-Asparaginase 
Current form of L-Asparaginase therapy involves injecting the drug preparation either 
intravenously or intramuscularly. Preparation from E coli and Erwinia Chrisanthemi 
asparaginases are clinically available in the market now along with peglylated form of E 
coli asparaginase. E. coli and Erwinia asparaginases have identical mechanisms of action 
but their kinetic properties are different, and patients sensitive to one drug have often show 
tolerance to the other. There are several different types of L-Asparaginase available 
commercially, each derived from a different bacterium. Patients receiving treatment with 
L-Asparaginase derived from Escherichia coli (E. coli), who develop hypersensitivity to 
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that form of the enzyme, may be able to continue treatment with Erwinase® as the enzymes 
are immunologically distinct. Immunologic cross-reaction between antibodies against 
various formulations of native L-Asparaginase from E. coli and PEG L-Asparaginase has 
been reported, but no such reaction has been found against Erwinia L-Asparaginase [66]. 
Antibodies targeting E. coli derived L-Asparaginase have been shown not to cross-react 
with Erwinase. Eriwinia asparaginase is recommended to patients having high allergic 
reactions [67]. To eliminate the high immunogenic reactions of E Coli Asparaginase the 
protein was conjugated with PEG group (PEG Asparaginase) which reduced the side 
effects to a greater extend. Available commercial forms of L-Asparaginase are listed in 
Table 3. 
 
Table 3: Available commercial forms of L-Asparaginase 
Source Marketed by Trade name 
E.coli asparaginase EUSA Pharma, Oxford, UK Kidrolase 
 Ovation Pharmaceuticals, Deerfield, Illinois Elspar 
 Bayer AG, Leverkusen, Germany Crasnitin 
 Sanofi-Aventis, Paris, France Leunase 
 
Kyowa Hakko, Tokyo, Japan 
Rhône-Poulenc Rorer 
Asparaginase Medac  
Ciderolase 
PEG-asparaginase 
Sigma-Tau Pharmaceuticals, Inc. 
Gaithersburg, Maryland 
Oncaspar 
Eriwinia asparaginase EUSA Pharma, UK Erwinase 
 
Speywood 
 
Erwinase 
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2.6 Treatment and side effects 
Current treatment protocols of ALL and lymphosarcoma do not employ L-Asparaginase as 
a single agent it is always a part of multiple agent regimens and combined with drugs 
having definitive immunosuppressive effects. Acute lymphoblastic leukemia cell lines 
have been markedly inhibited by asparaginases. L-Asparaginase induces cell cycle arrest 
in G1 phases, which results in apoptosis of leukemia cells [68]. E.coli L-Asparaginase has 
been found to phosphorylate endogenous polypeptides in immune cells. Products of L-
Asparaginase hydrolysis action especially NH4+ ions diffuse into the cytosol of the tumor 
cell and modify the pH, which activates signal transduction pathways associated with 
phosphorylation of substrates [69]. It was reported that L-Asparaginase has been found to 
be effective in nasal type leukemia treatment [70]. It was found that the deamination of 
glutamine may enhance the anti-leukemic effect of L-Asparaginase [71]. Asparagine levels 
have been found to be strongly correlated with plasma L-Asparaginase activity, even at 
low enzyme activities of <50 U/l. Asparagine levels have an inverse relation with L-
Asparaginase activity and chemotherapy. L-Asparaginase results in decreased asparagine, 
glutamine and 5 other amino acid levels in pediatric patients with ALL [72]. 
Besides minor side effects such as an allergic reaction and vomiting, L-Asparaginase 
therapy has some serious side effects which can be fatal in some cases. Onset of venous 
thrombosis in children undergoing histopathologic disease due to ALL therapy has been 
reported by Sahoo and Hart in 2003 [73]. Meyer et al has reported L-Asparaginase 
associated hyperlipidemia with hyper viscosity syndrome in a patient with T-cell 
lymphoblast lymphoma [74]. Neutropenic enterocolitis has been observed as an unusual 
acute complication of neutropenia, associated with leukemia and lymphoma. 
M. Tech Thesis, June 2016 
 
17 
 
Hypersensitivity reactions to chemotherapeutic antineoplastic agents such as L-
Asparaginase have been reported. Tubular and glomerular dysfunction due to ALL 
chemotherapy was reported by Ikarashi et al., (2004) [75]. Ching et al., (2004) observed 
that the L-Asparaginase treatment causes urethral obstruction during treatment of ALL 
[76]. Myocardial ischemia has been observed in a patient with acute lymphoblastic 
leukemia during asparaginase treatment [77].  
2.7 Large scale production of L-Asparaginase 
The usage of this enzyme in the clinical field requires large scale production using 
microbes. Different modes of operation and different microbes are used for the large scale 
production. Each operation requires careful controlling of parameters such temperature, 
pH, dissolved oxygen content, agitation rate etc.  
2.7.1 Production of L-Asparaginase by Submerged fermentation  
Submerged fermentation is a process in which the growth of microorganisms takes place 
in liquid broth medium which is optimized with required nutrients to have a better 
cultivation of micro-organisms. This involves growing carefully the selected 
microorganisms in closed reactor containing the fermentation medium and a high 
concentration of oxygen. Submerged fermentation has well established equipment that 
make use of the existing micro-organisms. Bacteria is commonly used as source in this 
process as it requires high moisture content.  Production of L-Asparaginase from various 
microbial sources using submerged fermentation is listed in Table 4. Fungal species such 
as Aspergillus niger, A.terreus, A.tamari, Fusarium and Pencillium are reported for L-
Asparaginase production by submerged fermentation [78]. Studies on optimization of 
culture media and environment conditions in both batch and continuous SmF have been 
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reported. Synthesis of L-Asparaginase hinge on type of the organism and various 
parameters such as pH of medium, temperature, nutrient composition, inoculation 
concentration, dissolved oxygen concentration and fermentation time [79]. 
 
Table 4. Summary of fermentation conditions and microbial cultures for production of L-
Asparaginase using SmF 
Fermentation 
medium (w/v) 
Microorganism 
Fermentation 
Parameters 
L-Asparaginase 
yield 
Specific 
Activity 
Reference 
Autolyzed yeast 
extract 
Serratia 
marcescens 
ATCC 60 
Temperature 26 
°C pH 5.0;  
3.7 IU/mL  [80] 
Tryptone 0.05; 
Glucose  0.1;  
Yeast 0.05 
Erwinia 
aroideae NRRL 
B-138 
Temperature 28 
°C, pH 7.0 
1,250 IU 
international unit /g 
dry weight of cells 
 [38] 
Peptone 4.0 
Streptomyces  
griseus ATCC 
10137 
 
pH-8.5; batch 117 IU/L  [81] 
tryptone 0.5;  
yeast extract 0.3; 
NaCl 0.2; 
Glucose 0; 
 FeCl3 2 µM; 
1 mM MgCl2; 
0.2 mM CaCl2 
 
Thermus 
thermophilus 
Temperature 
70°C, pH 7.0 
- 
840 IU/mg 
protein. 
[45] 
proline medium 2 
Aspergillus 
terreus 
Temperature 
30°C, pH 6.2 
58.8 U/L  [8] 
Asparagine 
dextrose salt 
medium 
Streptomyces 
griseus NIOT-
VKMA29 
Temperature 
35°C, pH 8.0 
56.78 IU/mL  [82] 
 
     2.7.2      Production of L-Asparaginase by Solid state fermentation 
L-Asparaginase is usually produced through submerged fermentation technique. But this 
method has several disadvantages such as low product yield, high cost and it generates 
large amount of waste water effluent. Solid state fermentation is extensively used in various 
processes such as bioremediation, bio detoxification of various hazardous compounds, 
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production of various therapeutic enzymes and secondary metabolites and as an effective 
alternative to submerged fermentation. Solid State Fermentation (SSF) is defined as the 
process in which the growth of micro-organism takes place on a solid substrate in the 
absence or presence of little water or with minimal moisture content. In this technique solid 
substrate is considered as the only source for the microorganisms. SSF use agricultural 
wastes and industrial residues that are cheap and readily available material as source of 
growth for microorganism for the production of low volume-high cost products.  L-
Asparaginase was produced from marine actinomycetes by SSF and SmF and a comparison 
showed that L-Asparaginase with higher activity is isolated from SSF process [83]. 
Substrates such as wheat bran, coconut oil cake, black sesame oil cake, soy bean meal,   
sugar cane bagasse are commonly used for the SSF production of the enzyme. Mishra 
(2006) testified maximum production of L-Asparaginase from Aspergillus niger using 
Glycine max as substrate followed by that of, Phaseolus mungo and Cajanus cajan [35]. 
Many statistical methods have been reported in optimization of process for the extraction 
of L-Asparaginase from microbes. Estimation of nutritional and environmental factors are 
essential for the production of enzyme. Statistically designed and planned experiments 
screen and evaluate the response of different parameters which enhances the enzyme 
production. L-Asparaginase production on wheat bran using Cladosporium sp. was studied 
with five experimental design variables pH, temperature, moisture content, inoculum 
concentration and time using response surface methodology with enzyme yield as 3.74 U 
[84]. L-Asparaginase production on sesame oil cake using Aspergillus niger C4 in a SSF 
column bioreactor was optimized for three variables (aeration rate, bed thickness and 
temperature) which  resulted in maximum L-Asparaginase yield of 310 U/gds [85].   
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Table 5. Summary of microbial cultures and fermentation conditions for production of L-
Asparaginase using SSF 
Substrate Microorganism 
Fermentation 
Parameters 
Enzyme 
Activity 
Specific 
Activity 
Reference 
Soy bean 
meal 
Pseudomonas 
aeruginosa 
50071 
Temperature 37 °C 
; pH 7.4; moisture 
content 40% (w/v); 
142.18 IU  [46] 
Soy bean 
meal 
Pseudomonas 
aeruginosa 
50071 
Temperature 37 °C 
; pH 7.4; moisture 
content 50% (w/v); 
 
1900 
IU/mg 
[86] 
Glycine 
max 
Aspergillus 
niger 
Temperature 30 ± 
2° C; pH 6.5; 
moisture content 
70% (w/v) 
40.9 ± 3.35 
U/g of dry 
substrate 
 [35] 
Red gram 
husk.  
Bengal 
gram husk. 
Ground nut 
cake. 
Coconut 
oil cake. 
B. circulans 
(MTCC 8574) 
Temperature 30 ° 
C; pH 7.0; 
moisture content 
40% (w/v) 
780 U/g of 
dry substrate 
600 U/g of 
dry substrate 
360 U/g of 
dry substrate 
380 U/g of 
dry substrate 
 [48] 
groundnut 
oil cake, 
Aspergillus 
terreus MTCC 
1782 
Temperature 30 ° 
C; pH 6.2 
30.35 
IU/mL 
 [42] 
Rice bran 
with 
nutrients 
Serratia 
marcescens 
SB08 
Temperature 30 ° 
C; pH 7.0; 
moisture content 
50% (w/v) 
79.84 U/g  [49] 
Soya bean 
meal 
Fusarium 
equiseti 
initial moisture 
content 70% 
8.51 IU  [54] 
Wheat bran 
Cladosporium 
sp. 
moisture content of 
58%, pH - 5.8, 
temperature 30°C 
3.74 U  [84] 
Coconut 
oil cake 
Serratia 
marcescens 
initial moisture 
content of substrate 
50%, 
Temperature 
35.5°C and pH -
7.4. 
5.86 U/g of 
dry substrate 
 [51] 
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Chapter 3 
MATERIALS AND METHODS 
 
3.1 Chemicals and reagents 
Chemicals and reagents used in the isolation and screening study were of analytical grade 
and obtained from Himedia and SRL. L-asparagine used in the assay is from Sigma 
Aldrich, India. 
The agricultural substances used for the isolation and SSF studies were purchased from 
local market in Hyderabad. 
3.2 Fungal species 
MTCC 1782 Aspergillus Terreus was purchased from Microbial Type Culture Collection 
& Gene Bank, Institute of Microbial Technology, Chandigarh, India. The strain was 
revived and maintained on potato dextrose slants. The organism was sub-cultured every 
month and stored at 4±1°C. 
3.3 Collection of soil samples 
Soil samples were collected from Western Ghats of and Kerala and samples were collected 
in air tight containers and kept at room temperature in laboratory. 
3.4 Plate assay for the screening of L-Asparaginase production 
Modified Czapek Dox medium(MCM) with composition  glucose 2 g L-1, L-asparagine 10 
g L-1 , KH2PO4 1.52 g L
-1, KCl 0.52 g L-1, MgSO4.7H2O 0.52 g L
-1, FeSO4.7H2O trace, 
ZnSO4. 7H2O trace and agar 18 g L
-1 was prepared. 2.5 % (w/v) stock solution of the phenol 
red dye was prepared and MCM medium was supplemented with 0.009% phenol red dye. 
pH of this medium was adjusted to 6.2 using 1 M NaOH [87].  Prepared media was 
autoclaved and poured into pre-sterilized plates. Control plates were prepared with NaNO3 
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as nitrogen source instead of L-Asparagine. Both MCM and control plates were inoculated 
with fungal strains and incubated for 96 h. The MCM plates will change the color from 
yellow to pink if the microbe is producing L-Asparaginase enzyme. The enzyme will 
hydrolyze the asparagine present in the media to ammonia and L-aspartate which increase 
the pH of the media which causes phenol red to change the color from yellow to pink. So 
a pink color change will be visible on the plate around the colony. 
Mahajan et al developed a different MCM plate assay with Bromothymol blue as the dye 
instead of phenol red. 0.04% of stock solution of the Bromothymol blue dye was prepared 
and 0.007% BTB dye was supplemented in MCM medium. Final pH of the media was 
adjusted at 5.5 using 1M NaOH [88]. The BTB dye will change the color of the media from 
yellow to blue if the microbe shows asparaginase activity. 007% BTB is reported to have 
sharp color contrast zone, ranging from yellow at acidic pH, green at neutral pH to blue at 
alkaline pH. 
3.5 Plate assay for L-Glutaminase production 
L-glutaminase activity of the fungal strains are detected by supplementing the modified 
Czapek Dox medium with L-Glutamine as sole nitrogen source instead of L-asparagine. 
Strains were inoculated and observed for color change from yellow to pink in case of 
phenol red dye and yellow to blue for BTB dye. 
3.6 Plate assay for Urease production 
MCD medium without nitrogen source was autoclaved and 1% filter sterilized urea 
solution was added to MCD media for detection of urease producing fungi. This method is 
followed for producing MCD media with urease because otherwise urease decomposes at 
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high temperature during sterilization. Test strains were inoculated and observed for change 
in the color of the medium. 
3.7 Isolation and screening of fungi from soil and agricultural samples 
Fungal strains are isolated from 4 different soil samples from Western Ghats and 4 different 
agricultural substrates, cotton seed oil cake, wheat bran, rice husk and red gram husk by 
both serial dilution method and soil plate method. In serial dilution method 5 g of sample 
is mixed in 50 ml of .9% saline solution and incubated for 30 minutes in an incubator 
shaker. This is then serially diluted up to 10-6 dilution and inoculated on the Modified 
Czapek Dox agar plates incorporated with .009% phenol red dye with L-asparagine as a 
sole nitrogen source and incubated at 30°C for 4 days. In soil plate method 2 g sample is 
uniformly spread on the MCD agar plates and incubated for 4 days at 30°C [89]. Once 
fungal colonies are grown the plate shows pink coloration if the fungi is producing L-
Asparaginase. Then those fungal strains were again screened separately in MCD plates and 
if found positive it is grown in potato dextrose slants and stored at 4oC. For the 
reproducibility of results the isolated strains are again screened in liquid MCD medium. 
3.8 Analytical methods 
3.8.1  Assay of L-Asparaginase 
L-Asparaginase activity is obtained by measuring the ammonia liberated when L-
Asparaginase is allowed to react with L-asparagine. The liberated ammonia is then reacted 
with Nessler’s regent which forms an orange precipitate. The optical density of this 
solution is measured in a spectrophotometer [Beckman Coulter] at 425 nm. A modified 
protocol of Writson (1970) [90] as described by Sanjay Kumar et al. is used for the assay 
[91]. A freshly prepared potato dextrose slant of the fungal strain was supplemented with 
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1 mL of autoclaved DD water to prepare the inoculum. 50 mL autoclaved MCD medium 
in a 250 mL Erlenmeyer flasks was inoculated with 2% of the inoculum [cell density: 6 X 
108] and incubated in an orbital shaker incubator at 30oC and 180 rpm. Samples were 
withdrawn at regular intervals to analyze for L-Asparaginase production. 
The enzyme samples are filtered and the supernatant was analyzed for extracellular L-
Asparaginase activity. The enzyme assay mixture consisted of 900 µL of freshly prepared 
L-asparagine (10 mM) in Tris–HCl buffer (pH 8.6) and 100 µL of filtered crude enzyme. 
The reaction mixture was incubated at 37 o C for 30 min and the reaction was stopped by 
adding 100 µL of 1.5M trichloroacetic acid (TCA). The reaction mixture was centrifuged 
at 10,000 rpm for 5 min at 4 o C to remove the precipitates. The ammonia released in the 
supernatant was determined using colorimetric technique by adding 100 µL Nessler’s 
reagent into the sample containing 100 µL supernatant and 800 µL distilled water. The 
contents in the sample were vortex mixed and incubated at room temperature for 10 min 
and OD was measured at 425 nm against the blanks that received TCA before the addition 
of crude enzyme. The ammonia produced in the reaction was determined based on the 
standard curve obtained with ammonium sulfate. One unit (IU) of L-Asparaginase activity 
was defined as the amount of the enzyme that liberates 1 µM of ammonia/ min at 37 o C. 
Specific activity is expressed as units/mg of protein. 
3.8.2  Protein estimation 
The total protein content of the samples were determined according to the method 
described by Lowry et al., (1951) [92]. The protein assay mixture consisted of 200 µL of 
crude extract of enzyme and 1mL of freshly prepared complex forming reagent (2% 
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Na2CO3 in 0.1 N NaOH: 1.0% CuSO4.5H2O: 2% potassium sodium tartrate ≡ 100:1:1). 
The contents in the sample were vortex mixed and incubated at room temperature for 15 
min. Then 100 µL of freshly prepared diluted Folin phenol reagent with distilled water 
(1:1) was added and vortex mixed and kept in the dark at room temperature for 30 min. 
OD at 660 nm was measured against the blank (no crude enzyme, 200 µL distilled water). 
The protein concentration in the reaction was determined based on a standard curve 
obtained with bovine serum albumin as standard. 
3.9 SSF studies 
Solid state fermentation studies of the selected isolate W5 (strain with the high enzyme 
index) was done in 250 mL Erlenmeyer flasks. 20 g of the sterilized agricultural substrate 
moistened to 60% of the dry weight with sodium phosphate buffer of pH 7 is taken in in 
the flask and inoculated with 1 mL inoculum prepared by adding 1 mL of autoclaved DD 
water in to a freshly prepared potato dextrose slant. It is then incubated at 35o C for 96 h in 
an incubator and samples are collected and analyzed at equal intervals. 
For the assay of L-Asparaginase enzyme produced in solid state fermentation 2g substrate 
is withdrawn at equal intervals of time and 10 mL (1:5) of pH 7 sodium phosphate buffer 
is added and it is kept in an incubator shaker at 30 o C and 180 rpm for one hour. After that 
the sample is filtered and filtered in Whatman no 1 filter paper. This enzyme extract is used 
for the assay as discussed in the previous section. 
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Chapter 4 
RESULTS AND DISCUSSION 
 
4.1 Isolation of fungal strains from different sources 
A total of 30 different fungal isolates were obtained from the isolation studies conducted 
with 4 different soil samples and 4 different agricultural substrates. Out of which 20 
isolates are found to have L-Asparaginase activity and can be used for the production of 
the potential enzyme. Out of these most of the fungi belonged to Aspergillus, Rhizopus 
and Pencillium species. 
Table 6. List of isolation sources and strains 
Source Region Description No. of 
isolates 
Name of the isolates 
Soil samples Kerala Soil samples were 
collected from 
Western Ghats 
 
5 S1.1,S1.4 S2.1, S3.1, S3.4 
Agricultural 
residues 
Substrates were 
collected from 
local market. 
Cotton seed oil cake 
Rice husk 
Wheat bran 
Red gram husk 
6 
2 
5 
2 
C1,C3,C4,C5,C6,C7 
R1,R2 
W1,W2,W3,W4,W5 
P2,P3 
   
 
4.2 Screening studies of the isolated fungal sps 
This study involved the screening of all the isolated fungi for the production of multiple 
enzymes. Most of the L-Asparaginase producing bacteria or fungi produce the enzyme 
along with L-glutaminase and urease enzymes which are not desired at all for the 
therapeutic applications as described in the previous paragraphs. So all the isolated fungi 
were screened for the production of L-Asparaginase, L-glutaminase and urease using 
modified Czapek Dox medium implemented with asparagine, glutamine and urea 
respectively as the sole nitrogen sources as described in materials and methods. Screening 
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studies were conducted with both phenol red and BTB dyes for the reproducibility of the 
results. These amidohydrolases, cleave amine groups and liberates aspartic acid and 
ammonia in case of L-Asparaginase, glutamic acid and ammonia in case of L-glutaminase 
and carbonic acid and ammonia in the case of urease. Ammonia liberated in the medium 
further reacts with water to produce NH4OH resulting in increase in the pH of the medium 
which changes the color of the dye in the medium. 
Phenol red dye is yellow at acidic pH and turns pink at alkaline pH, presence of pink color 
zone around the colonies on MCD plates with different nitrogen sources is due to the 
liberation of corresponding enzyme. BTB dye change the color from yellow at acidic pH 
to green ant neutral and blue at alkaline pH. Twenty isolates showed pink zone around the 
colonies indicating increase in pH. Fungal isolates W3, W5, C3, and C7 showed presence of 
pink color zone around the fungal colonies only on the asparagine plate indicating that 
these isolates produce only L-Asparaginase enzyme and no glutaminase or urease enzyme 
is produced. MTCC 1782 strain showed pink color zone when grown on L-asparagine, L-
glutamine and urea plates indicating that strain produces 3 enzymes. To ensure 
reproducibility, all the isolates were screened with BTB as both the dyes are formulated 
for screening the hydrolysis of L-glutamine, L-asparagine and urea. Among phenol red and 
BTB, 0.007% of BTB dye showed sharp and clear color zone which makes it better than 
the phenol red dye. Methyl red was incorporated as pH indicator in the recent study to 
screen L-Asparaginase and L-glutaminase producing microorganism [93]. Out of twenty 
strains four show only asparaginase activity 4 show asparaginase and urease activity and 
12 show asparaginase glutaminase and urease activity. 12 strains produce all the three 
enzymes i.e. 60% of the total isolated strains. This is the first study on isolation and 
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screening of glutaminase and urease free L-Asparaginase from fungi. Also, several fungi 
were identified that have potential of producing glutaminase free L-Asparaginase. 
Screening results of all the strains are indicated in table 7 along with colony diameter and 
zone diameter. 
 
Figure 4. Screening of isolated strains for multiple enzyme activity using MCD 
plates amended with .009% phenol red 
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Figure 5. Screening of isolated strains for multiple enzyme activity using MCD plates 
amended with .007% BTB 
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4.3 Semi quantitative studies of the isolated fungal strains  
 Enzyme activity can be calculated semi quantitatively by calculating the relative ratio of 
zone diameter to colony diameter called zone index. The comparison of zone index values 
of isolates S3.4, W3, W5, C3, C7 and MTCC 1782 Aspergillus terreus strain using phenol red 
and BTB dye are given in Table 8. Measurement of zone diameter and colony diameter is 
depicted in figure 6. Using this qualitative plate assay rapid screening of the fungi for the 
synthesis of the enzyme by direct visualization and activity of the enzyme can be measured. 
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Gulati et al., revealed that equivalent relation exists between zone index and enzyme 
activity measured from broth. In the current work enzyme index varied from 0.8 to 4, which 
is in line with study conducted by Abhinav et al. 2010 [94].  Isolated fungi W3, W5, C3, C7 
and S3.4 were cultured in PDA slants, later morphologically identified as Culvularia sp., 
Rhizopus sp., and Aspergillus sp., respectively [95]. Microscopic pictures of these strains 
are shown below. 
Figure 6. Picture showing zone diameter and colony diameter 
 
 
 
 
 
 
 
 
Table 7: Fungal species screened for multi enzyme production 
      L-Asparaginase enzyme index 
 
Isolation 
source 
Isolate 
Control 
(NaNO3) 
Urea 
L-
asparagi
ne 
L-
glutam
ine 
Colony 
diameter 
(cm) 
Zone 
Diameter 
(cm) 
Zone 
index 
Soil from 
Western 
Ghats 
S1.1 - + + + 2 6.5 3.25 
S1.4 - + + + 2.1 3.9 1.86 
S2.1 - + + + 3.2 8.5 2.66 
S3.4 - + + - 3.3 6.8 2.06 
S4.1 - + + + 2 8.5 4.25 
Red gram 
husk 
P2 - + + + 3.5 5.5 1.57 
P3 - + + + 2.5 3 1.20 
Rice husk R1 - + + + 2.6 6 2.31 
b 
a 
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R3 - + + + 3.7 6.3 1.70 
Wheat bran 
W1 - + + - 6 6.5 1.08 
W2 - + + + 4 7 1.75 
W3 - - + - 3.7 4.7 1.27 
W4 - + + + 2 4 2.00 
W5 - - + - 2.2 2.6 1.18 
Cotton seed 
oil cake 
C1 - + + + 2.5 6 2.40 
C3 - - + - 3.8 5.5 1.45 
C4 - + + - 7.5 7 0.93 
C5 - + + - 7.5 7 0.93 
C6 - + + + 8.5 7 0.82 
C7 - - + - 3.5 5.5 1.57 
 MTCC 
1782 
- + + + 2.5 6.0 2.4 
 
 
Table 8: L-Asparaginase enzyme index measurement using phenol red and Bromothymol 
blue amended in MCD medium and species observed under Light microscope. 
 
 
Isolate 
Phenol Red Bromothymol Blue 
 
Species 
Colony 
diameter 
(cm) 
Zone 
Diameter 
(cm) 
Zone 
index 
Colony 
diameter 
(cm) 
Zone 
Diameter 
(cm) 
Zone 
index 
        
W3 2.40 2.40 1.00 3.70 4.70 1.27 Rhizopus sp. 
W5 8.80 8.80 1.00 2.20 2.60 1.18 Rhizopus sp. 
C3 3.00 3.00 1.00 3.80 5.50 1.45 Aspergillus sp. 
C7 3.00 4.60 1.53 3.50 5.50 1.57 Aspergillus sp. 
S3.4 4.30 6.70 1.56 3.30 6.80 2.06 Curvularia sp. 
MTCC1782 2.50 6.00 2.40 2.50 6.00 2.40 Aspergillus sp. 
 
 
Figure 7. Microscopic pictures of isolated strains 
    a                           b                                 c                               d                                e 
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a - C3: Aspergillus sp. 
b - C7: Aspergillus sp. 
c - W3: Rhizopus sp. 
d - W5: Rhizopus sp. 
e - S3.4: Curvularia sp.  
   
4.4 Quantitative studies of L-Asparaginase activity 
The L-Asparaginase activity of the four isolated strains with no glutaminase and urease 
activity are measured in liquid broth studies along with MTCC 1782 strain using the 
protocol of Sanjay et al (2011) as described in section 3.8.1. The observed values are 
plotted in fig 8. MTCC strain is found to have the highest activity at 72 h. Among the four 
isolated strains C7 has highest activity. All the strains exhibit the highest activity at 72 h.  
 
Figure 8. Activity plots of isolated fungal strains 
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Table 9. Activity values of isolated fungal strains 
 
4.5 Protein estimation studies 
Protein values of the 4 isolated strains are calculated with Lowry’s method as described in 
section 3.8.2. The specific activity values of the fungi are obtained by dividing the activity 
values with corresponding protein content values. 
Table 10. Protein content values of isolated strains. 
 Time h 24 48 72 96 
 
 
Protein 
content  
mg/ml 
MTCC 0.265 0.418 0.479 0.483 
C3 0.300 0.617 0.629 0.598 
C7 0.309 0.474 0.518 0.470 
W3 0.342 0.437 0.430 0.419 
W5 0.361 0.553 0.591 0.534 
 
 Time h 24 48 72 96 
 
 
 
Activity 
(U/mL) 
MTCC 7.63 7.57 54.92 21.15 
C3 10.57 13.52 15.42 10.07 
C7 1.22 3.52 44.09 25.29 
W3 7.57 7.35 12.51 3.51 
W5 8.54 12.43 21.57  8.77 
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Table 11. Specific activity values of isolated strains. 
 
Figure 9. Specific activity plots for isolated strains. 
 
 
 
 
 
 
 
 
 
 Time h 24 48 72 96 
 
 
Specific 
activity 
U/mg 
MTCC 28.80 18.10 114.64 43.77 
C3 35.25 21.92 24.51 16.83 
C7 3.96 7.43 85.17 53.80 
W3 22.15 16.81 29.08 8.36 
W5 23.69 22.48 36.50 16.43 
0 20 40 60 80 100
0
20
40
60
80
100
120
S
p
e
ci
fic
 A
ct
iv
ity
 (
U
/m
g
)
Time (h)
 MTCC
 C3
 C7
 W3
 W5
M. Tech Thesis, June 2016 
 
36 
 
4.6 L-Asparaginase activity studies in SSF 
The solid state fermentation studies of two strains C7 and W5 were conducted in an 
Erlenmeyer flask with 20 g wheat bran as the substrate. The moisture content was adjusted 
to 60% with pH 7 sodium phosphate buffer and incubated at 30°C. The following results 
are observed. The SmF is found to have more activity compared to SSF. And C7 has more 
activity than W5 in SSF also. 
Table 12. Comparison of SSF and SmF activity values for W5 
W5 
time h SSF activity U/ml SMF activity U/ml 
24 4.76 8.54 
48 6.21 12.43 
72 15.28 21.57 
96 8.45 8.77 
 
Figure 10. Comparison of SSF and SmF activity values for W5 
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Table 13. Comparison of SSF and SmF activity values for C7 
 
 
 
 
 
 
 
Figure 11. Comparison of SSF and SmF activity values for C7 
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Chapter 5 
CONCLUSION AND FUTURE STUDIES 
 
In conclusion, L-Asparaginase from various microbial sources exhibits properties that acts 
as an anti-neoplastic agent and reduces acrylamide levels in food. Even though Bacterial 
L-Asparaginase is clinically applied for treatment of ALL, it induces adverse reactions. For 
food and pharmaceutical industry applications, further studies to extract L-Asparaginase 
from novel sources such as eukaryotic organisms and marine sources should be explored 
such that extracted enzyme has high specificity towards L-asparagine and prolonged half-
life.   
In the present study, 4 fungal strains producing glutaminase and urease free L-
Asparaginase was screened and isolated so as to reduce the multiple enzyme activity 
thereby reducing toxic effects.  Efforts are made to isolate L-Asparaginase from various 
microbial sources and understand the mechanism of L-Asparaginase sensitivity to improve 
efficacy of the enzyme. The strain C7 is found to have the highest activity out of the four 
strains without any glutaminase and urease activity and the activity values are 44.09 U/ml 
and 22.41 U/ml in SmF and SSF respectively.  
Further studies should be carried out in the following areas. 
 Optimization of the various factors which are affecting the production of the 
enzyme including temperature, pH, media components, inoculum concentration, 
rpm etc. 
 Statistical design methods can be used for the optimization of these factors which 
influence the activity. 
M. Tech Thesis, June 2016 
 
39 
 
 Scale up of the enzyme production to semi pilot and pilot plant levels. 
 Downstream processing of the isolated enzyme. 
 Cytotoxic and immunogenic properties of the isolated enzyme. 
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APPENDIX 
A.1 Calculation of L-Asparaginase activity 
A stock solution of ammonium sulfate with concentration 1 µm/ml was prepared in 50 mM 
tris buffer of pH 8. It is diluted with milliQ water to get different concentrations viz .2 to 
1. Ammonium sulfate is a divalent alt of ammonia hence 1 mol of ammonium sulfate 
release 2 mol of ammonia. Hence 1 µm/ml solution of ammonium sulfate is equivalent to 
2 µm/ml of ammonia. Experiments were conducted in triplicates for the standard plot to 
observe the absorbance at 425 nm against appropriate blanks as described in the protocol. 
The obtained points are plotted in Microsoft Excel.  
Figure A.1. Ammonium sulfate standard curve for ammonia 
 
L-Asparaginase activity is calculated from the following equation. 
Activity (units/mL of enzyme) = (µ mole of NH3 liberated* V1)/(V2*t*V3) 
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V1- Volume of test sample in step 1, V2- volume of step 1 supernatant used in step 2, V3- 
Volume of crude enzyme used in step 1, t- time of incubation. 
One unit of L-Asparaginase (U) is defined as the amount of enzyme which liberates 1µmol 
of ammonia per min at 37 °C. 
A.2 Calculation of protein values 
A stock solution of .1 mg/ml of bovine serum albumin is prepared in milliQ water. It was 
diluted to get standard solutions of various concentrations from 0.01 to 0.1 mg/mL. 
Experiments were done for standard curve in triplicates for the standard values and 
absorbance is measured at 660 nm against appropriate blank as described in protocol. The 
obtained points are plotted in Microsoft Excel. 
Figure A.2. Standard curve of bovine serum albumin. 
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